Pages that link to "Q47138288"
Jump to navigation
Jump to search
The following pages link to Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer (Q47138288):
Displaying 6 items.
- Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents. (Q55247585) (← links)
- Diprophylline inhibits non-small cell lung cancer A549 cell proliferation and migration, and promotes apoptosis, by downregulating PI3K signaling pathway. (Q64895371) (← links)
- Methylxanthines: Potential Therapeutic Agents for Glioblastoma (Q89995883) (← links)
- Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition (Q90401790) (← links)
- Roflumilast enhances cisplatin-sensitivity and reverses cisplatin-resistance of ovarian cancer cells via cAMP/PKA/CREB-FtMt signalling axis (Q90705767) (← links)
- Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling (Q98771220) (← links)